These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4223062)

  • 21. Experimental cardiac hypertrophy.
    Fanburg BL
    N Engl J Med; 1970 Mar; 282(13):723-32. PubMed ID: 4244509
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial response to stress in cardiac hypertrophy and heart failure: effect of antihypertensive drugs.
    Sen S
    Ann N Y Acad Sci; 1999 Jun; 874():125-33. PubMed ID: 10415526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cardiac performance in clinical heart disease. Interactions between contractile state mechanical abnormalities and ventricular compensatory mechanisms.
    Mason DT
    Am J Cardiol; 1973 Sep; 32(4):437-48. PubMed ID: 4273893
    [No Abstract]   [Full Text] [Related]  

  • 24. [The strength and rate of myocardial contractions in cardiac hypertrophy caused by experimental defect and training].
    Meerson FZ; Rozanova LS
    Patol Fiziol Eksp Ter; 1967; 11(1):18-22. PubMed ID: 4239062
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of embryonal organ-specific RNA on myocardial hypertrophy].
    Skuba ND; Levkova NA
    Biull Eksp Biol Med; 1979 Nov; 88(11):621-3. PubMed ID: 94272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy.
    Haddad GE; Coleman BR; Zhao A; Blackwell KN
    Basic Res Cardiol; 2004 Sep; 99(5):317-27. PubMed ID: 15309409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
    Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
    Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Absence, in the hypertrophied rat heart caused by aortocaval fistula, of several metabolic and electrophysiological changes seen in other models of hypertrophy].
    Thollon C; Aussedat J; Verdetti J; Kreher P
    C R Acad Sci III; 1985; 300(16):607-12. PubMed ID: 3158383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluid and electrolyte shifts relating cardiac hypertrophy with normal growth.
    Horwood DM; Beznak M
    Can J Physiol Pharmacol; 1971 Nov; 49(11):951-8. PubMed ID: 4259851
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1.
    Martin C; Yu AY; Jiang BH; Davis L; Kimberly D; Hohimer AR; Semenza GL
    Am J Obstet Gynecol; 1998 Mar; 178(3):527-34. PubMed ID: 9539521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental hypertrophy of the heart and its regression in rats--changes in functional reserve].
    Cihák R; Kolár F; Papousek F; Procházka J; Ost'ádal B; Widimský J
    Cesk Fysiol; 1988; 37(6):538-40. PubMed ID: 2977300
    [No Abstract]   [Full Text] [Related]  

  • 32. Ameliorative role of gemfibrozil against partial abdominal aortic constriction-induced cardiac hypertrophy in rats.
    Singh AP; Singh R; Krishan P
    Cardiol Young; 2015 Apr; 25(4):725-30. PubMed ID: 24905340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
    Oh KS; Lee JH; Yi KY; Lim CJ; Park BK; Seo HW; Lee BH
    Eur J Pharmacol; 2017 Mar; 799():94-102. PubMed ID: 28163023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nature and significance of alterations in myocardial compliance.
    Covell JW; Ross J
    Am J Cardiol; 1973 Sep; 32(4):449-55. PubMed ID: 4269700
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanical properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding.
    Yin FC; Spurgeon HA; Weisfeldt ML; Lakatta EG
    Circ Res; 1980 Feb; 46(2):292-300. PubMed ID: 6444279
    [No Abstract]   [Full Text] [Related]  

  • 37. Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats.
    Olivetti G; Quaini F; Lagrasta C; Ricci R; Tiberti G; Capasso JM; Anversa P
    Am J Pathol; 1992 Jul; 141(1):227-39. PubMed ID: 1385927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function in myocardial hypertrophy.
    Taylor RR; Papadimitriou JM; Hopkins BE
    Adv Cardiol; 1974; 12(0):246-55. PubMed ID: 4275819
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of endocrine factors in the pathogenesis of cardiac hypertrophy.
    Cohen J
    Circ Res; 1974 Aug; 35(2):suppl II:49-57. PubMed ID: 4276488
    [No Abstract]   [Full Text] [Related]  

  • 40. Myocardial hypertrophy and cardiac failure: a complex interrelationship.
    Massie BM
    Am J Med; 1983 Sep; 75(3A):67-74. PubMed ID: 6226198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.